Registration and Continental Breakfast
Stern Lobby
Welcome and Introduction
Ash Tewari, MBBS, MCh
Lifetime Achievement Award in Bladder Cancer Research
Presented by Ash Tewari,MBBS, MCh, FRCS (Hon.), Dsc. (Hon.) and Peter Wiklund, MD, PhD
Introduction to Live Case
Peter Wiklund, MD, PhD, MD
8:15 am
Surgeon: Peter Wiklund, MD, PhD
Moderator: Jim Porter, MD
Panel: Peter Albers, MD; Aditya Bagrodia, MD
Moderator: James Porter, MD
Panelists: Lee Zhao, MD; Vito Pansadoro, MD
Does 3D-Guided Models for Robotic Partial Nephrectomy Have Better Outcomes?
Ketan Badani, MD, FRCS (Hon.)
The Evolving Landscape of the Robotic Nephrectomy. Multiport, Single Port, Whats Next?
Senthil Nathan, FRCS, Mphil
Does 3D-Guided Models for Robotic Partial Nephrectomy Have Better Outcomes?
Vito Pansadoro, MD
Advances in Kidney Cancer Ablation: Current Uses and Emerging Techniques
Leonardo Reis, MD, PhD
Single Port Nephrectomy: Complications Troubleshooting. Tips & Tricks
Rene Sotelo Noguera, MD
From Hintori to 3 Xi: the Japanese Experience with Surgical Robotics
Ryoichi Shiroki, MD, PhD
The Future of Surgery: Exploring New Robotic Platforms in the U.S.
Jim Porter, MD
Q&A
Moderator: Craig Rogers, MD
Single Port Surgery
FOR: Simone Crivellaro, MD, MHA; Ketan Badani, MD, FRCS
AGAINST: Jim Porter, MD; Brian Shuch, MD
Lunch / Visit Exhibits
Moderator: Reza Mehrazin, MD
Panel: Ashok Hemal, FACS, FRCS; Jon Sfakianos, MD; Peter Wiklund, MD, PhD
Neoadjuvant vs Adjuvant Chemotherapy in Bladder Cancer
Cora Sternberg, MD, FACP
ctDNA in Bladder Cancer
John Sfakianos, MD
State of Bladder-Sparing in Muscle-Invasive Bladder Cancer
Jason Efstathiou, MD DPhil
Urine ctDNA Overview
Francois Audenet, MD
Female Organ Sparing in Cystectomy
Juhana Rautiola, MD, PhD
Q&A
Prostate Sparing Cystectomy
Doug Scherr, MD
Intravesical Therapy in BCG-Unresponsive Bladder CA
Katie Murray, MD
Low Pressure Robotic Cystectomy and Considerations of Mixed Gas Pneumoperitoneum
Nikhil Vasdev, MBBS, MRCS
Salvage Bladder Cancer Therapy
James A. Brown, MD, MHA
Q&A
Moderators: Peter Wiklund, MD
Panel: Peter Albers, MD; James Porter, MD; Reza Mehrazin, MD
Primary RPLND vs Chemotherapy in Testes Cancer
Reza Mehrazin, MD
Robotic RPLND in Primary vs Post Chemotherapy
Peter Albers, MD
Techniques for Robot-Assisted RPLND
James Porter, MD
Trends in RPLND: Should We Be Doing More?
Aditya Bagrodia, MD
Closing Remarks
Peter Wiklund, MD, PhD
Copyright © 2024 Prostate Cancer Symposium and World Urologic Oncology Symposium - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.